Bayer exec says the quiet part out loud
As this blog has pointed out before, the Moderna and Pfizer products marketed as "vaccines" COVID-19 are mRNA therapies, despite the incessant shilling about them being "vaccines".
Stefan Oelrich, president of Bayer’s Pharmaceuticals Division, made these comments at this year’s World Health Summit, which took place in Berlin from October 24-26 and hosted 6,000 people from 120 countries. Oelrich told his fellow international “experts” from academia, politics, and the private sector that the novel mRNA COVID “vaccines” are actually “cell and gene therapy” that would have otherwise been rejected by the public if not for a “pandemic” and favorable marketing.
“We are really taking that leap [to drive innovation] – us as a company, Bayer – in cell and gene therapies … ultimately the mRNA vaccines are an example for that cell and gene therapy. I always like to say: if we had surveyed two years ago in the public – ‘would you be willing to take a gene or cell therapy and inject it into your body?’ – we probably would have had a 95% refusal rate,” stated Oelrich.
The full video is on YouTube — and we have the money shot right here for you:
As you can see here, he insists these products are "vaccines", but leaves no doubt that marketing them this way is exactly why they didn't get a resounding no, I will not take gene / mRNA therapy from 95% of the public. Of course, it definitely helped him look like less of a liar that both CDC and Merriam-Webster, in an act of Gleichschaltung, redefined the term "vaccine" to accommodate these therapies.
Readers of this blog know that, while we were initially on board with the term "vaccines", we've been slowly abandoning the term "vaccines" to refer to these mRNA gene editing products — because the first loss is to unconsciously adopt your enemy's false position. It's hard to be consistent, and so, for that, we bite this bullet.
Gotta say, man, what masterful stroke of propaganda — Göbbels level — to piggyback on the good reputation that vaccines have, in order to falsely market gene therapies.
And now we have a public figure from the same industry admit that our current stance, however unpopular, has been the correct one all along.